Gliadorphin: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Gliadorphin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
Line 7: | Line 7: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{medical-stub}} | {{medical-stub}} |
Latest revision as of 17:52, 4 September 2012
This article needs additional citations for verification. (June 2007) (Learn how and when to remove this template message) |
Gliadorphin (also known as gluteomorphin) is an opioid peptide which is formed during digestion of the gliadin component of the gluten protein. It is usually broken down into amino acids by digestion enzymes. It has been hypothesized that children with autism have abnormal leakage from the gut of this compound, which then passes into the brain and disrupts brain function. This is partly the basis for the gluten-free, casein-free diet. Studies of this diet have had important methodological flaws and the scientific evidence is not adequate to make treatment recommendations.[1]
- Structure: Tyr-Pro-Gln-Pro-Gln-Pro-Phe
- Molecular weight: 875.43 g/mol